BioSpace News Archive

NEWARK, Calif. , Feb. 19, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that Dinesh V. Patel , Ph.D., President and Chief Executive Officer, will present a corporate overview at the upcoming the SVB Leerink 9th Annual Global Healthcare Conference in New York . Presentation details: Event: SVB Leerink 9th Annual Global Healthcare Confere

Webcast scheduled for Wednesday, February 26th at 11:30 a.m. Eastern Time

Feb. 19, 2020 12:00 UTC First-ever automated insulin delivery with the tubeless Omnipod Insulin Management System and personal smartphone control Initially compatible with Dexcom G6 CGM, with no fingersticks* required Integration with the next generation Dexcom G7 CGM system, once available SAN DIEGO & ACTON, Mass.--( BUSINESS WIRE )-- DexCom , Inc. (NASDAQ: DXCM) and Insulet Corporation (NASDAQ: PODD), have announced a global commercialization agreem

Feb. 19, 2020 12:00 UTC PHILADELPHIA--( BUSINESS WIRE )-- Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy, today announced that management is scheduled to present at two upcoming investor conferences. Cowen 40th Annual Health Care Conference Monday, March 2, 2020 1:30 PM ET Boston, MA Oppenheimer 30th Annual Healthcare Conferen

Feb. 19, 2020 11:59 UTC Bristol-Myers Squibb to Hold Investor Day on April 2 NEW YORK--( BUSINESS WIRE )-- Bristol-Myers Squibb Company (NYSE: BMY) today announced that it will hold an Investor Day in New York City on Thursday, April 2, 2020. Giovanni Caforio, M.D. , chairman and chief executive officer, and members of the leadership team will discuss the Company’s strategy, pipeline and business opportunities. The event will be webcast simultaneously at http://investor.b

Bonifatius Hospital in Lingen to Be Among the First in Europe to Offer the Latest Advances in Stereotactic Radiosurgery

DUBLIN, Ireland and CHICAGO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced its participation at the 9 th Annual SVB Leerink Global Healthcare Conference. The conference will be held from February 25 th – February 27 th in New York City. Corey Fish

SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases, today announced that Joseph Payne, Chief Executive Officer, will provide a corporate overview at the Cowen & Co. 40 th Annual Healthcare Conference, and the 32 nd Annual ROTH Conference. Cowen & Co. 40 th Annual Healthcare Conference Date:

VIVUS, Inc. (Nasdaq:VVUS) (the “Company”), a biopharmaceutical company, announced today that its Korean marketing partner, Alvogen, has launched Qsymia (phentermine and topiramate extended-release) in the Republic of Korea

SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that Scott Struthers, Ph.D., Founder and Chief Executive Officer, will participate in a fireside chat at the 9 th Annual SVB Leerink Global Healthcare Conference. The fireside chat will take place on Wednesda